Product Information
PREGABALIN 225 MG CAPSULE is a generic product labeled by Ascend Laboratories, LLC, priced at $0.0562 per EA under NDC 67877046890. Its NADAC has been published 364 times since Sep 4, 2019.
FDA first approved this application on Jul 19, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
225 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877046890
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PREGABALINApproval Type
Generic (ANDA)
FDA Application
ANDA207799FDA Approved
7/19/2019
TE Code
AB
On Market Since
7/21/2019
Price Statistics
The NADAC for PREGABALIN 225 MG CAPSULE has been published 364 times since Sep 4, 2019, and over the history we have for it it has declined 76.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0562 per EA |
|---|---|
| All-time high | $0.2382 (Sep 11, 2019) |
| All-time low | $0.0529 (Nov 20, 2024) |
| 52-week high | $0.0702 |
| 52-week low | $0.0543 |
| Median price | $0.0900 |
| Average price | $0.1057 |
| Largest weekly change | -29.0% (Nov 20, 2024) |
| Weeks tracked | 364 |
| Tracking since | Sep 4, 2019 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PREGABALIN 225 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 225 MG CAPSULE, manufactured by Ascend Laboratories, LLC, is $0.0562 per EA (NDC 67877046890), effective Aug 19, 2026.
How has the price of PREGABALIN 225 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PREGABALIN 225 MG CAPSULE has declined 76.4%. It has been tracked across 364 weekly CMS publications since Sep 4, 2019.
What are the highest and lowest recorded NADAC prices for PREGABALIN 225 MG CAPSULE?
Since Sep 4, 2019, the NADAC for PREGABALIN 225 MG CAPSULE has ranged from a low of $0.0529 (Nov 20, 2024) to a high of $0.2382 (Sep 11, 2019), with a median of $0.0900 per EA.
Are there cheaper alternatives to PREGABALIN 225 MG CAPSULE?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PREGABALIN 225 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures PREGABALIN 225 MG CAPSULE?
PREGABALIN 225 MG CAPSULE (NDC 67877046890) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.